Document
falsefalse--12-31--12-31Q2Q2201720172017-06-302017-06-3010-Q10-Q00015745400001583994179192604YesNoLarge Accelerated FilerNon-accelerated FilerPhysicians Realty TrustPhysicians Realty L.P.P1Y10.230.015000000001359660131576775661359660131576775660.00850.0140.010.01550.0120.0180.00900.01450.01550.01250.0120.018850000000400000000750000001500000002500000000.0430.04240.04090.04740.04030.02871359660131576775661359660131576775660000343620753992653436207539926500P3YP1YP2YP3Y
0001574540
2017-01-01
2017-06-30
0001574540
2017-07-31
0001574540
doc:PhysiciansRealtyLPMember
2017-01-01
2017-06-30
0001574540
2017-06-30
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2017-06-30
0001574540
2016-12-31
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2017-06-30
0001574540
2016-04-01
2016-06-30
0001574540
2016-01-01
2016-06-30
0001574540
2017-04-01
2017-06-30
0001574540
us-gaap:NoncontrollingInterestMember
2017-01-01
2017-06-30
0001574540
us-gaap:RetainedEarningsMember
2017-01-01
2017-06-30
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2017-01-01
2017-06-30
0001574540
us-gaap:AdditionalPaidInCapitalMember
2017-01-01
2017-06-30
0001574540
doc:OperatingPartnershipNoncontrollingInterestMember
2016-12-31
0001574540
us-gaap:CommonStockMember
2017-01-01
2017-06-30
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2016-12-31
0001574540
us-gaap:ParentMember
2017-01-01
2017-06-30
0001574540
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2017-01-01
2017-06-30
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2016-12-31
0001574540
us-gaap:AdditionalPaidInCapitalMember
2016-12-31
0001574540
us-gaap:ParentMember
2016-12-31
0001574540
us-gaap:RetainedEarningsMember
2016-12-31
0001574540
us-gaap:NoncontrollingInterestMember
2016-12-31
0001574540
us-gaap:RetainedEarningsMember
2017-06-30
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2017-01-01
2017-06-30
0001574540
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2017-06-30
0001574540
us-gaap:ParentMember
2017-06-30
0001574540
us-gaap:CommonStockMember
2016-12-31
0001574540
us-gaap:CommonStockMember
2017-06-30
0001574540
us-gaap:AdditionalPaidInCapitalMember
2017-06-30
0001574540
us-gaap:NoncontrollingInterestMember
2017-06-30
0001574540
2015-12-31
0001574540
2016-06-30
0001574540
doc:PhysiciansRealtyLPMember
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
2016-12-31
0001574540
doc:PhysiciansRealtyLPMember
2016-04-01
2016-06-30
0001574540
doc:PhysiciansRealtyLPMember
2016-01-01
2016-06-30
0001574540
doc:PhysiciansRealtyLPMember
2017-04-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2017-01-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2017-01-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2016-12-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2017-01-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2017-01-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
doc:PartnersCapitalMember
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:LimitedPartnerMember
2016-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2016-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2016-12-31
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-01-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:GeneralPartnerMember
2016-12-31
0001574540
doc:PhysiciansRealtyLPMember
doc:PartiallyOwnedPropertiesNoncontrollingInterestMember
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
2016-06-30
0001574540
doc:PhysiciansRealtyLPMember
2015-12-31
0001574540
doc:A2016ATMProgramMember
2017-01-01
2017-03-31
0001574540
doc:A2016ATMProgramMember
2017-04-01
2017-06-30
0001574540
doc:A2016ATMProgramMember
2017-01-01
2017-06-30
0001574540
doc:A2016ATMProgramMember
us-gaap:MaximumMember
us-gaap:PrivatePlacementMember
2016-08-05
2016-08-05
0001574540
us-gaap:SubsequentEventMember
2017-07-31
0001574540
2017-03-17
0001574540
2017-03-17
2017-03-17
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:PartnershipInterestMember
2017-03-31
0001574540
2017-06-12
2017-06-12
0001574540
doc:MinnetonkaMOBMember
2015-02-05
2015-02-05
0001574540
doc:PhysiciansRealtyLPMember
doc:JointventureOperatingPartnershipandMedicalCenterofNewAlbanyILLCMember
us-gaap:PartnershipInterestMember
2017-01-01
2017-06-30
0001574540
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2017-06-30
0001574540
2015-03-01
0001574540
2017-01-12
0001574540
doc:NashvilleMOBMember
2017-01-12
2017-01-12
0001574540
us-gaap:SeriesAPreferredStockMember
2015-02-05
2015-02-05
0001574540
doc:MinnetonkaMOBMember
us-gaap:PartnershipInterestMember
2016-04-01
0001574540
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
2017-01-01
2017-06-30
0001574540
doc:MezzanineLoanReceivableMember
2017-06-30
0001574540
doc:JointventureOperatingPartnershipandMedicalCenterofNewAlbanyILLCMember
2017-01-31
2017-01-31
0001574540
2015-03-01
2015-03-01
0001574540
doc:TermLoanReceivableMember
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:PartnershipInterestMember
2017-01-01
2017-03-31
0001574540
doc:PhysiciansRealtyLPMember
2017-01-01
2017-03-31
0001574540
us-gaap:SeriesAPreferredStockMember
2015-02-05
0001574540
doc:NashvilleMOBMember
2015-12-17
2015-12-17
0001574540
doc:JointventureOperatingPartnershipandMedicalCenterofNewAlbanyILLCMember
2017-01-31
0001574540
doc:BusinessCombinationAcquisitionPeriodTwoMember
doc:BelowMarketLeasesMember
2017-06-30
0001574540
doc:BelowMarketLeasesMember
2017-06-30
0001574540
us-gaap:AboveMarketLeasesMember
2017-06-30
0001574540
doc:BusinessCombinationAcquisitionPeriodTwoMember
doc:AbovemarketinplacegroundleaseMember
2017-06-30
0001574540
doc:BusinessCombinationAcquisitionPeriodOneMember
2017-03-31
0001574540
doc:BusinessCombinationAcquisitionPeriodTwoMember
us-gaap:AboveMarketLeasesMember
2017-06-30
0001574540
doc:BusinessCombinationAcquisitionPeriodTwoMember
us-gaap:LeasesAcquiredInPlaceMember
2017-06-30
0001574540
doc:BusinessCombinationAcquisitionPeriodOneMember
doc:BelowMarketGroundLeaseMember
2017-03-31
0001574540
doc:BelowMarketGroundLeaseMember
2017-06-30
0001574540
doc:BusinessCombinationAcquisitionPeriodTwoMember
2017-06-30
0001574540
doc:BusinessCombinationAcquisitionPeriodTwoMember
doc:BelowMarketGroundLeaseMember
2017-06-30
0001574540
doc:BusinessCombinationAcquisitionPeriodOneMember
doc:AbovemarketinplacegroundleaseMember
2017-03-31
0001574540
doc:BusinessCombinationAcquisitionPeriodOneMember
us-gaap:AboveMarketLeasesMember
2017-03-31
0001574540
doc:BusinessCombinationAcquisitionPeriodOneMember
us-gaap:LeasesAcquiredInPlaceMember
2017-03-31
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2017-06-30
0001574540
doc:AbovemarketinplacegroundleaseMember
2017-06-30
0001574540
doc:BusinessCombinationAcquisitionPeriodOneMember
doc:BelowMarketLeasesMember
2017-03-31
0001574540
us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
doc:GeorgiaPortfolioMember
2016-01-01
2016-06-30
0001574540
us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
doc:GeorgiaPortfolioMember
2016-04-01
2016-06-30
0001574540
us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
doc:GeorgiaPortfolioMember
2017-04-01
2017-06-30
0001574540
us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
doc:GeorgiaPortfolioMember
2017-01-01
2017-06-30
0001574540
doc:OrthopedicSportsInstituteoftheFoxValleyMember
2017-06-30
2017-06-30
0001574540
doc:PeachtreeDunwoodyMedicalCenterParkingDeckMember
2017-06-30
2017-06-30
0001574540
doc:MedStarStephensCrossingMember
2017-06-16
2017-06-16
0001574540
doc:BaylorCharlesA.SammonsCancerCenterMember
2017-06-30
2017-06-30
0001574540
doc:LoanInvestmentsMember
2017-01-01
2017-06-30
0001574540
doc:St.VincentPortfolioMember
2017-06-29
2017-06-29
0001574540
doc:A2017CHIPortfolioTranche1Member
2017-06-29
2017-06-29
0001574540
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2017-01-01
2017-06-30
0001574540
us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
doc:GeorgiaPortfolioMember
2017-02-23
2017-02-23
0001574540
us-gaap:LoansMember
2017-01-01
2017-06-30
0001574540
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2017-04-01
2017-06-30
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2017-01-01
2017-06-30
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2017-04-01
2017-06-30
0001574540
doc:BelowMarketLeasesMember
2016-01-01
2016-06-30
0001574540
us-gaap:AboveMarketLeasesMember
2016-01-01
2016-06-30
0001574540
us-gaap:AboveMarketLeasesMember
2017-01-01
2017-06-30
0001574540
doc:BelowMarketGroundLeaseMember
2016-04-01
2016-06-30
0001574540
us-gaap:AboveMarketLeasesMember
2017-04-01
2017-06-30
0001574540
doc:BelowMarketGroundLeaseMember
2016-01-01
2016-06-30
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2016-04-01
2016-06-30
0001574540
doc:LeaseholdInterestMember
2016-01-01
2016-06-30
0001574540
doc:LeaseholdInterestMember
2016-04-01
2016-06-30
0001574540
us-gaap:AboveMarketLeasesMember
2016-04-01
2016-06-30
0001574540
doc:AboveMarketGroundLeaseMember
2016-04-01
2016-06-30
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2016-01-01
2016-06-30
0001574540
doc:AboveMarketGroundLeaseMember
2017-01-01
2017-06-30
0001574540
doc:BelowMarketLeasesMember
2017-04-01
2017-06-30
0001574540
doc:LeaseholdInterestMember
2017-04-01
2017-06-30
0001574540
doc:BelowMarketLeasesMember
2017-01-01
2017-06-30
0001574540
doc:BelowMarketGroundLeaseMember
2017-04-01
2017-06-30
0001574540
doc:LeaseholdInterestMember
2017-01-01
2017-06-30
0001574540
doc:AboveMarketGroundLeaseMember
2016-01-01
2016-06-30
0001574540
doc:BelowMarketGroundLeaseMember
2017-01-01
2017-06-30
0001574540
doc:BelowMarketLeasesMember
2016-04-01
2016-06-30
0001574540
doc:AboveMarketGroundLeaseMember
2017-04-01
2017-06-30
0001574540
doc:LeaseholdInterestMember
2017-06-30
0001574540
us-gaap:AboveMarketLeasesMember
2016-12-31
0001574540
doc:BelowMarketGroundLeaseMember
2016-12-31
0001574540
doc:AboveMarketGroundLeaseMember
2017-06-30
0001574540
doc:BelowMarketLeasesMember
2016-12-31
0001574540
us-gaap:LeasesAcquiredInPlaceMember
2016-12-31
0001574540
doc:LeaseholdInterestMember
2016-12-31
0001574540
doc:AboveMarketGroundLeaseMember
2016-12-31
0001574540
doc:CreditAgreementAmendmentMember
2016-06-10
2016-06-10
0001574540
doc:SeriesCMember
2016-01-07
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RevolvingCreditFacilityMember
2017-06-30
0001574540
doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member
us-gaap:MortgagesMember
us-gaap:MaximumMember
2016-12-31
0001574540
us-gaap:SeriesAMember
2016-01-07
0001574540
doc:SeriesCMember
us-gaap:SeniorNotesMember
2016-08-11
0001574540
doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member
us-gaap:MortgagesMember
2016-12-31
0001574540
doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member
us-gaap:MortgagesMember
us-gaap:MinimumMember
2016-12-31
0001574540
doc:SeriesDMember
us-gaap:SeniorNotesMember
2016-01-07
0001574540
us-gaap:SeriesAMember
us-gaap:SeniorNotesMember
2016-08-11
0001574540
doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member
us-gaap:MortgagesMember
us-gaap:MaximumMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2016-01-01
2016-12-31
0001574540
doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member
us-gaap:MortgagesMember
2016-12-31
0001574540
us-gaap:InterestRateSwapMember
us-gaap:UnsecuredDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2016-07-07
0001574540
us-gaap:SeniorNotesMember
2017-01-26
0001574540
doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member
us-gaap:MortgagesMember
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member
us-gaap:MortgagesMember
2017-06-30
0001574540
us-gaap:SeniorNotesMember
2016-01-07
0001574540
doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member
us-gaap:MortgagesMember
us-gaap:MinimumMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
us-gaap:SeriesBMember
2016-01-07
0001574540
doc:CreditAgreementAmendmentMember
doc:TermLoanMember
2016-06-10
2016-06-10
0001574540
us-gaap:RevolvingCreditFacilityMember
2017-06-30
0001574540
doc:TermLoanMember
2017-06-30
0001574540
doc:TermLoanMember
2016-07-07
0001574540
doc:SeriesCMember
us-gaap:SeniorNotesMember
2016-01-07
0001574540
us-gaap:SeniorNotesMember
2017-03-07
0001574540
doc:CreditAgreementAmendmentMember
2016-06-10
0001574540
us-gaap:SeriesAMember
us-gaap:SeniorNotesMember
2016-01-07
0001574540
doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member
us-gaap:MortgagesMember
us-gaap:MaximumMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
us-gaap:SeniorNotesMember
2016-08-11
0001574540
doc:CreditAgreementAmendmentMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:MinimumMember
2016-06-09
0001574540
doc:SeriesDMember
2016-01-07
0001574540
us-gaap:SeniorNotesMember
2017-03-07
2017-03-07
0001574540
doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member
us-gaap:MortgagesMember
us-gaap:MaximumMember
2017-06-30
0001574540
doc:MortgageNotesBearingVariableInterestDueIn2017and2018Member
us-gaap:MortgagesMember
us-gaap:MinimumMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2016-01-01
2016-12-31
0001574540
doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member
us-gaap:MortgagesMember
us-gaap:MinimumMember
2017-06-30
0001574540
doc:CreditAgreementAmendmentMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2016-06-10
2016-06-10
0001574540
doc:CreditAgreementAmendmentMember
doc:TermLoanMember
2016-06-10
0001574540
us-gaap:SeriesBMember
2016-08-11
0001574540
us-gaap:SeriesAMember
2016-08-11
0001574540
us-gaap:SeriesBMember
us-gaap:SeniorNotesMember
2016-08-11
0001574540
doc:CreditAgreementAmendmentMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:MaximumMember
2016-06-10
0001574540
us-gaap:SeriesBMember
us-gaap:SeniorNotesMember
2016-01-07
0001574540
doc:CreditratingbelowBBBorBAA3Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBplusorBAA1Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBorBAA3Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingbelowBBBorBAA3Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastAorA3Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBorBAA2Member
doc:BaseRateLoansMember
us-gaap:RevolvingCreditFacilityMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBorBAA3Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastAorA3Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBorBAA2Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBplusorBAA1Member
doc:BaseRateLoansMember
doc:TermLoanMember
us-gaap:BaseRateMember
2017-01-01
2017-06-30
0001574540
us-gaap:MortgagesMember
2017-06-30
0001574540
doc:SeniorUnsecuredNotesDueAugust2025to2027Member
us-gaap:SeniorNotesMember
2016-12-31
0001574540
doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member
us-gaap:SeniorNotesMember
2016-12-31
0001574540
doc:UnsecuredTermLoanDueJune2023Member
us-gaap:UnsecuredDebtMember
2016-12-31
0001574540
doc:RevolvingCreditFacilityDueSeptember2020Member
us-gaap:RevolvingCreditFacilityMember
2016-12-31
0001574540
doc:SeniorUnsecuredNoteDue2027Member
us-gaap:SeniorNotesMember
2017-06-30
0001574540
doc:RevolvingCreditFacilityDueSeptember2020Member
us-gaap:RevolvingCreditFacilityMember
2017-06-30
0001574540
doc:SeniorUnsecuredNotesDueAugust2025to2027Member
us-gaap:SeniorNotesMember
2017-06-30
0001574540
doc:SeniorUnsecuredNoteDue2027Member
us-gaap:SeniorNotesMember
2016-12-31
0001574540
us-gaap:MortgagesMember
2016-12-31
0001574540
doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member
us-gaap:SeniorNotesMember
2017-06-30
0001574540
doc:MortgageNotesBearingVariableInterestMember
us-gaap:MortgagesMember
2016-12-31
0001574540
doc:MortgageNotesBearingVariableInterestMember
us-gaap:MortgagesMember
2017-06-30
0001574540
doc:UnsecuredTermLoanDueJune2023Member
us-gaap:UnsecuredDebtMember
2017-06-30
0001574540
doc:SeniorUnsecuredNotesDueAugust2025to2027Member
us-gaap:SeniorNotesMember
us-gaap:MaximumMember
2017-06-30
0001574540
doc:SeniorUnsecuredNotesDueAugust2025to2027Member
us-gaap:SeniorNotesMember
us-gaap:MinimumMember
2017-06-30
0001574540
doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member
us-gaap:SeniorNotesMember
us-gaap:MinimumMember
2017-06-30
0001574540
doc:RevolvingCreditFacilityDueSeptember2020Member
us-gaap:RevolvingCreditFacilityMember
2017-01-01
2017-06-30
0001574540
doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member
us-gaap:SeniorNotesMember
us-gaap:MaximumMember
2017-06-30
0001574540
doc:CreditratingatleastAorA3Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastAorA3Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBorBAA2Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingbelowBBBorBAA3Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBplusorBAA1Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBorBAA3Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBplusorBAA1Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBorBAA3Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingatleastBBBorBAA2Member
doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:CreditratingbelowBBBorBAA3Member
doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
doc:UnsecuredTermLoanDueJune2023Member
us-gaap:UnsecuredDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2017-01-01
2017-06-30
0001574540
us-gaap:RevolvingCreditFacilityMember
2016-06-10
2016-06-10
0001574540
us-gaap:InterestRateSwapMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2016-12-31
0001574540
us-gaap:InterestRateSwapMember
2016-07-07
0001574540
2016-07-07
0001574540
us-gaap:InterestRateSwapMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2017-06-30
0001574540
doc:UnsecuredTermLoanDueJune2023Member
us-gaap:UnsecuredDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2016-07-07
2016-07-07
0001574540
us-gaap:InterestRateSwapMember
2017-01-26
0001574540
us-gaap:InterestRateSwapMember
2017-03-07
2017-03-07
0001574540
doc:PerformanceBasedRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2017-04-01
2017-06-30
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2017-04-01
2017-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:DirectorMember
2017-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2014-08-07
2014-08-07
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2017-01-01
2017-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2017-01-01
2017-06-30
0001574540
doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2017-06-30
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2014-08-07
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2016-01-01
2016-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2016-04-01
2016-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2016-01-01
2016-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:OfficerMember
2017-03-01
2017-03-31
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2017-04-01
2017-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
2017-06-30
0001574540
doc:MarketBasedRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:OfficerMember
2017-03-01
2017-03-31
0001574540
doc:TrusteeAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:DirectorMember
2016-03-01
2016-03-31
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2013-07-24
0001574540
doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2017-01-01
2017-06-30
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2016-04-01
2016-06-30
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2017-06-30
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
2016-12-31
0001574540
doc:TrusteeAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2017-01-01
2017-06-30
0001574540
doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2016-12-31
0001574540
doc:TrusteeAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2016-12-31
0001574540
doc:TrusteeAwardsRestrictedStockUnitsRSUsMember
doc:EquityIncentivePlan2013PlanMember
2017-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:DirectorMember
2017-01-01
2017-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:OfficerMember
2017-01-01
2017-06-30
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:MaximumMember
2017-01-01
2017-06-30
0001574540
us-gaap:RestrictedStockMember
doc:EquityIncentivePlan2013PlanMember
us-gaap:MinimumMember
2017-01-01
2017-06-30
0001574540
us-gaap:InterestRateSwapMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2017-06-30
0001574540
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2017-06-30
0001574540
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2016-12-31
0001574540
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2017-06-30
0001574540
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2016-12-31
0001574540
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2016-12-31
0001574540
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2017-06-30
0001574540
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2016-12-31
0001574540
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2017-06-30
0001574540
us-gaap:InterestRateSwapMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueMeasurementsRecurringMember
2016-12-31
0001574540
us-gaap:FairValueMeasurementsNonrecurringMember
2017-06-30
0001574540
us-gaap:OperatingExpenseMember
doc:ParkingAirAndGroundLeasesMember
2017-01-01
2017-06-30
0001574540
us-gaap:OperatingExpenseMember
doc:ParkingAirAndGroundLeasesMember
2016-01-01
2016-06-30
0001574540
us-gaap:OperatingExpenseMember
doc:ParkingAirAndGroundLeasesMember
2016-04-01
2016-06-30
0001574540
us-gaap:OperatingExpenseMember
doc:ParkingAirAndGroundLeasesMember
2017-04-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:IN
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:KY
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:AZ
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:NE
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
stpr:TX
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:GeographicConcentrationRiskMember
doc:AllotherstatesMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
doc:USOncologyMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
doc:BaylorScottandWhiteHealthMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
doc:CHINebraskaMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
doc:CHISt.AlexiusNorthDakotaMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
doc:RemainingPortfolioMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
doc:CHIKentuckyOneHealthMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
doc:CHIPortfolioMember
2017-01-01
2017-06-30
0001574540
us-gaap:SalesRevenueServicesNetMember
us-gaap:CustomerConcentrationRiskMember
doc:TopfivetenantrelationshipsMember
2017-01-01
2017-06-30
0001574540
us-gaap:RestrictedStockMember
2016-01-01
2016-06-30
0001574540
us-gaap:RestrictedStockMember
2017-01-01
2017-06-30
0001574540
us-gaap:RestrictedStockMember
2017-04-01
2017-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
2017-04-01
2017-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
2016-01-01
2016-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
2016-04-01
2016-06-30
0001574540
us-gaap:RestrictedStockUnitsRSUMember
2017-01-01
2017-06-30
0001574540
us-gaap:RestrictedStockMember
2016-04-01
2016-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockUnitsRSUMember
2016-01-01
2016-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockMember
2016-01-01
2016-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockMember
2017-04-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockUnitsRSUMember
2016-04-01
2016-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockUnitsRSUMember
2017-04-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockMember
2017-01-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockUnitsRSUMember
2017-01-01
2017-06-30
0001574540
doc:PhysiciansRealtyLPMember
us-gaap:RestrictedStockMember
2016-04-01
2016-06-30
0001574540
us-gaap:SubsequentEventMember
2017-07-05
2017-07-05
0001574540
us-gaap:SubsequentEventMember
2017-07-31
2017-07-31
0001574540
us-gaap:SubsequentEventMember
2017-07-05
doc:instruments
doc:properties
iso4217:USD
xbrli:shares
xbrli:pure
doc:buildings
xbrli:shares
doc:segment
iso4217:USD
doc:parking_deck
utreg:Rate
doc:states
doc:healthcareproperty
doc:condominium_units
utreg:sqft
doc:mezzanine_loan
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2017
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-36007 (Physicians Realty Trust)
Commission file number: 333-205034-01 (Physicians Realty L.P.)
PHYSICIANS REALTY TRUST
PHYSICIANS REALTY L.P.
(Exact Name of Registrant as Specified in its Charter)
|
| | |
Maryland (Physicians Realty Trust) Delaware (Physicians Realty L.P.) (State of Organization) | | 46-2519850 80-0941870 (IRS Employer Identification No.) |
| | |
309 N. Water Street, Suite 500 Milwaukee, Wisconsin (Address of Principal Executive Offices) | | 53202 (Zip Code) |
(414) 367-5600
(Registrant’s Telephone Number, Including Area Code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Physicians Realty Trust Yes ý No o Physicians Realty L.P. Yes o No ý
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Physicians Realty Trust Yes ý No o Physicians Realty L.P. Yes o No ý
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
| |
Physicians Realty Trust | Large accelerated filer ý Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o Emerging growth company o |
| |
Physicians Realty L.P. | Large accelerated filer o Accelerated filer o Non-accelerated filer ý (Do not check if a smaller reporting company) Smaller reporting company o Emerging growth company o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Physicians Realty Trust o Physicians Realty L.P. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Physicians Realty Trust Yes o No ý Physicians Realty L.P. Yes o No ý
The number of the Registrant’s common shares outstanding as of July 31, 2017 was 179,192,604.
EXPLANATORY NOTE
This Quarterly Report on Form 10-Q combines the Quarterly Reports on Form 10-Q for the quarter ended June 30, 2017 of Physicians Realty Trust (the “Trust”), a Maryland real estate investment trust, and Physicians Realty L.P. (the “Operating Partnership”), a Delaware limited partnership. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” “our company,” the “Company,” and “Physicians Realty” refer to the Trust, together with its consolidated subsidiaries, including the Operating Partnership. References to the “Operating Partnership” mean collectively the Operating Partnership together with its consolidated subsidiaries. In this report, all references to “common shares” refer to the common shares of the Trust and references to “our shareholders” refer to shareholders of the common shares of the Trust, the term “OP Units” refers to partnership interests of the Operating Partnership and the term “Series A Preferred Units” refers to Series A Participating Redeemable Preferred Units of the Operating Partnership. As of July 31, 2017, no Series A Preferred Units are outstanding.
The Trust is a self-managed real estate investment trust (“REIT”) formed primarily to acquire, selectively develop, own, and manage healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems. The Trust’s operations are conducted through the Operating Partnership and wholly-owned and majority-owned subsidiaries of the Operating Partnership. The Trust, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership.
The Trust conducts substantially all of its operations through the Operating Partnership. As of June 30, 2017, the Trust held a 96.7% interest in the Operating Partnership and owns no Series A Preferred Units. Apart from this ownership interest, the Trust has no independent operations.
Noncontrolling interests in the Operating Partnership, shareholders’ equity of the Trust and partners’ capital of the Operating Partnership are the primary areas of difference between the consolidated financial statements of the Trust and those of the Operating Partnership. OP Units not owned by the Trust are accounted for as limited partners’ capital in the Operating Partnership’s consolidated financial statements and as noncontrolling interests in the Trust’s consolidated financial statements. The differences between the Trust’s shareholders’ equity and the Operating Partnership’s partners’ capital are due to the differences in the equity issued by the Trust and the Operating Partnership, respectively.
The Company believes combining the Quarterly Reports of the Trust and the Operating Partnership, including the notes to the consolidated financial statements, into this single report results in the following benefits:
| |
• | a combined report enhances investors’ understanding of the Trust and the Operating Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business; |
| |
• | a combined report eliminates duplicative disclosure and provides a more streamlined and readable presentation, as a substantial portion of the Company’s disclosure applies to both the Trust and the Operating Partnership; and |
| |
• | a combined report creates time and cost efficiencies through the preparation of one combined report instead of two separate reports. |
To help investors understand the significant differences between the Trust and the Operating Partnership, this report presents the following separate sections for each of the Trust and the Operating Partnership:
| |
• | the consolidated financial statements in Item 1 of this report; |
| |
• | certain accompanying notes to the consolidated financial statements, including Note 3 (Acquisitions and Dispositions) and Note 14 (Earnings Per Share and Earnings Per Unit); |
| |
• | controls and procedures in Item 4 of this report; and |
| |
• | the certifications of the Chief Executive Officer and the Chief Financial Officer included as Exhibits 31 and 32 to this report. |
PHYSICIANS REALTY TRUST AND PHYSICIANS REALTY L.P.
Quarterly Report on Form 10-Q
for the Quarter Ended June 30, 2017
Table of Contents
|
| | |
| | Page Number |
| | |
| | |
| | |
| | |
Financial Statements of Physicians Realty Trust | |
| | |
| | |
| | |
| | |
| | |
| | |
Financial Statements of Physicians Realty L.P. | |
| | |
| | |
| | |
| | |
| | |
| | |
Notes for Physicians Realty Trust and Physicians Realty L.P. | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts may be forward-looking statements within the meaning of the federal securities laws. In particular, statements pertaining to our capital resources, property performance and results of operations contain forward-looking statements. Likewise, all of our statements regarding anticipated growth in our funds from operations and anticipated market conditions, demographics and results of operations are forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology such as “believe,” “expect,” “outlook,” “continue,” “project,” “may,” “will,” “should,” “seek,” “approximately,” “intend,” “plan,” “pro forma,” “estimate” or “anticipate” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans, expectations or intentions.
These forward-looking statements reflect the views of our management regarding current expectations and projections about future events and are based on currently available information. These forward-looking statements are not guarantees of future performance and involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods which may be incorrect or imprecise and we may not be able to realize them. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:
| |
• | general economic conditions; |
| |
• | adverse economic or real estate developments, either nationally or in the markets where our properties are located; |
| |
• | our failure to generate sufficient cash flows to service our outstanding indebtedness, or our ability to pay down or refinance our indebtedness; |
| |
• | fluctuations or increases in interest rates; |
| |
• | fluctuations or increases in operating costs; |
| |
• | the availability, terms and deployment of debt and equity capital, including our unsecured revolving credit facility; |
| |
• | our ability to make distributions on our common shares; |
| |
• | general volatility of the market price of our common shares;
|
| |
• | our increased vulnerability economically due to the concentration of our investments in healthcare properties; |
| |
• | our geographic concentration in Texas causes us to be particularly exposed to downturns in the Texas economy or other changes in Texas market conditions; |
| |
• | changes in our business or strategy; |
| |
• | our dependence upon key personnel whose continued service is not guaranteed; |
| |
• | our ability to identify, hire and retain highly qualified personnel in the future;
|
| |
• | the degree and nature of our competition; |
| |
• | changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates and taxation of REITs, and similar matters;
|
| |
• | defaults on or non-renewal of leases by tenants; |
| |
• | decreased rental rates or increased vacancy rates; |
| |
• | difficulties in identifying healthcare properties to acquire and completing acquisitions; |
| |
• | competition for investment opportunities; |
| |
• | any adverse effects to Catholic Health Initiatives’ (“CHI”) business, financial position or results of operations that impact the ability of affiliates of CHI to pay us rent; |
| |
• | our failure to successfully develop, integrate and operate acquired properties and operations; |
| |
• | the impact of our investments in joint ventures; |
| |
• | the financial condition and liquidity of, or disputes with, any joint venture and development partners with whom we may make co-investments in the future; |
| |
• | cybersecurity incidents could disrupt our business and result in the compromise of confidential information; |
| |
• | our ability to operate as a public company; |
| |
• | changes in accounting principles generally accepted in the United States (GAAP); |
| |
• | lack of or insufficient amounts of insurance; |
| |
• | other factors affecting the real estate industry generally; |
| |
• | our failure to maintain our qualification as a REIT for U.S. federal income tax purposes; |
| |
• | limitations imposed on our business and our ability to satisfy complex rules in order for us to qualify as a REIT for U.S. federal income tax purposes; and |
| |
• | various other factors that may materially adversely affect us, or the per share trading price of our common shares, including: |
| |
• | the number of our common shares available for future issuance or sale; |
| |
• | our issuance of equity securities or the perception that such issuance might occur; |
| |
• | failure of securities analysts to publish research or reports about us or our industry; and |
| |
• | securities analysts’ downgrade of our common shares or the healthcare-related real estate sector. |
While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. We disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this report, except as required by applicable law. You should not place undue reliance on any forward-looking statements that are based on information currently available to us or the third parties making the forward-looking statements. For a further discussion of these and other factors that could impact our future results, performance or transactions, see Part II, Item 1A (Risk Factors) of this report, Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “Annual Report”), and Part II, Item 1A (Risk Factors) of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2017 (the “First Quarterly Report”).
PART I. Financial Information
Item 1. Financial Statements
Physicians Realty Trust
Consolidated Balance Sheets
(In thousands, except share and per share data)
|
| | | | | | | |
| June 30, 2017 | | December 31, 2016 |
| (unaudited) | | |
ASSETS | |
| | |
|
Investment properties: | |
| | |
|
Land and improvements | $ | 207,034 |
| | $ | 189,759 |
|
Building and improvements | 3,117,371 |
| | 2,402,643 |
|
Tenant improvements | 18,561 |
| | 14,133 |
|
Acquired lease intangibles | 381,875 |
| | 301,462 |
|
| 3,724,841 |
|
| 2,907,997 |
|
Accumulated depreciation | (229,633 | ) | | (181,785 | ) |
Net real estate property | 3,495,208 |
|
| 2,726,212 |
|
Real estate loans receivable | 47,923 |
| | 39,154 |
|
Investment in unconsolidated entity | 2,232 |
| | 2,258 |
|
Net real estate investments | 3,545,363 |
|
| 2,767,624 |
|
Cash and cash equivalents | 11,509 |
| | 15,491 |
|
Tenant receivables, net | 5,991 |
| | 9,790 |
|
Other assets | 103,028 |
| | 95,187 |
|
Total assets | $ | 3,665,891 |
|
| $ | 2,888,092 |
|
LIABILITIES AND EQUITY | |
| | |
|
Liabilities: | |
| | |
|
Credit facility | $ | 603,585 |
| | $ | 643,742 |
|
Notes payable | 619,675 |
| | 224,330 |
|
Mortgage debt | 173,958 |
| | 123,083 |
|
Accounts payable | 5,071 |
| | 4,423 |
|
Dividends and distributions payable | 38,381 |
| | 32,179 |
|
Accrued expenses and other liabilities | 51,042 |
| | 42,287 |
|
Acquired lease intangibles, net | 15,183 |
| | 9,253 |
|
Total liabilities | 1,506,895 |
|
| 1,079,297 |
|
| | | |
Redeemable noncontrolling interest - Series A Preferred Units (2016) and partially owned properties | 11,967 |
| | 26,477 |
|
| | | |
Equity: | |
| | |
|
Common shares, $0.01 par value, 500,000,000 common shares authorized, 157,677,566 and 135,966,013 common shares issued and outstanding as of June 30, 2017 and December 31, 2016, respectively | 1,576 |
| | 1,360 |
|
Additional paid-in capital | 2,313,443 |
| | 1,920,644 |
|
Accumulated deficit | (252,647 | ) | | (197,261 | ) |
Accumulated other comprehensive income | 12,928 |
| | 13,708 |
|
Total shareholders’ equity | 2,075,300 |
|
| 1,738,451 |
|
Noncontrolling interests: | |
| | |
|
Operating Partnership | 71,091 |
| | 43,142 |
|
Partially owned properties | 638 |
| | 725 |
|
Total noncontrolling interests | 71,729 |
|
| 43,867 |
|
Total equity | 2,147,029 |
|
| 1,782,318 |
|
Total liabilities and equity | $ | 3,665,891 |
|
| $ | 2,888,092 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty Trust
Consolidated Statements of Income
(In thousands, except share and per share data) (Unaudited)
|
| | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
| 2017 | | 2016 | | 2017 | | 2016 |
Revenues: | |
| | |
| | |
| | |
|
Rental revenues | $ | 58,015 |
| | $ | 42,196 |
| | $ | 117,107 |
| | $ | 77,051 |
|
Expense recoveries | 16,108 |
| | 9,552 |
| | 32,462 |
| | 17,455 |
|
Interest income on real estate loans and other | 2,476 |
| | 1,468 |
| | 3,696 |
| | 2,844 |
|
Total revenues | 76,599 |
|
| 53,216 |
|
| 153,265 |
|
| 97,350 |
|
Expenses: | |
| | |
| | |
| | |
|
Interest expense | 11,472 |
| | 4,279 |
| | 21,287 |
| | 8,476 |
|
General and administrative | 6,249 |
| | 4,926 |
| | 10,985 |
| | 9,047 |
|
Operating expenses | 20,519 |
| | 13,798 |
| | 42,608 |
| | 24,835 |
|
Depreciation and amortization | 28,123 |
| | 19,799 |
| | 56,056 |
| | 35,809 |
|
Acquisition expenses | 5,242 |
| | 3,256 |
| | 10,647 |
| | 6,633 |
|
Total expenses | 71,605 |
|
| 46,058 |
|
| 141,583 |
|
| 84,800 |
|
Income before equity in income of unconsolidated entities and gain on sale of investment properties: | 4,994 |
| | 7,158 |
| | 11,682 |
| | 12,550 |
|
Equity in income of unconsolidated entities | 29 |
| | 26 |
| | 57 |
| | 58 |
|
Gain on sale of investment properties | 5,308 |
| | — |
| | 5,308 |
| | — |
|
Net income | 10,331 |
|
| 7,184 |
|
| 17,047 |
|
| 12,608 |
|
Net income attributable to noncontrolling interests: | |
| | |
| | |
| | |
|
Operating Partnership | (314 | ) | | (201 | ) | | (461 | ) | | (374 | ) |
Partially owned properties (1) | (159 | ) | | (60 | ) | | (326 | ) | | (377 | ) |
Net income attributable to controlling interest | 9,858 |
|
| 6,923 |
|
| 16,260 |
|
| 11,857 |
|
Preferred distributions | (188 | ) | | (437 | ) | | (399 | ) | | (985 | ) |
Net income attributable to common shareholders: | $ | 9,670 |
|
| $ | 6,486 |
|
| $ | 15,861 |
|
| $ | 10,872 |
|
Net income per share: | |
| | |
| | |
| | |
|
Basic | $ | 0.06 |
| | $ | 0.05 |
| | $ | 0.11 |
| | $ | 0.09 |
|
Diluted | $ | 0.06 |
| | $ | 0.05 |
| | $ | 0.11 |
| | $ | 0.09 |
|
Weighted average common shares: | |
| | |
| | |
| | |
|
Basic | 155,366,080 |
| | 131,481,329 |
| | 147,221,602 |
| | 117,092,668 |
|
Diluted | 161,012,360 |
| | 135,944,722 |
| | 151,912,432 |
| | 121,575,247 |
|
| | | | | | | |
Dividends and distributions declared per common share and OP Unit | $ | 0.230 |
| | $ | 0.225 |
| | $ | 0.455 |
| | $ | 0.450 |
|
| |
| Includes amounts attributable to redeemable noncontrolling interests. No such adjustments are required for the three and six months ended June 30, 2016. |
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty Trust
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
|
| | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
| 2017 | | 2016 | | 2017 | | 2016 |
Net income | $ | 10,331 |
| | $ | 7,184 |
| | $ | 17,047 |
| | $ | 12,608 |
|
Other comprehensive income: | | | | | | | |
Change in fair value of interest rate swap agreements | (2,367 | ) | | — |
| | (780 | ) | | — |
|
Total other comprehensive income | (2,367 | ) | | — |
| | (780 | ) | | — |
|
Comprehensive income | 7,964 |
| | 7,184 |
| | 16,267 |
| | 12,608 |
|
Comprehensive income attributable to noncontrolling interests - Operating Partnership | (234 | ) | | (201 | ) | | (435 | ) | | (374 | ) |
Comprehensive income attributable to noncontrolling interests - partially owned properties | (159 | ) | | (60 | ) | | (326 | ) | | (377 | ) |
Comprehensive income attributable to common shareholders | $ | 7,571 |
| | $ | 6,923 |
| | $ | 15,506 |
| | $ | 11,857 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty Trust
Consolidated Statement of Equity
(In thousands) (Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Par Value | | Additional Paid in Capital | | Accumulated Deficit | | Accumulated Other Comprehensive Income | | Total Shareholders’ Equity | | Operating Partnership Noncontrolling Interest | | Partially Owned Properties Noncontrolling Interest | | Total Noncontrolling Interests | | Total Equity |
Balance at January 1, 2017 | $ | 1,360 |
| | $ | 1,920,644 |
| | $ | (197,261 | ) | | $ | 13,708 |
| | $ | 1,738,451 |
| | $ | 43,142 |
| | $ | 725 |
| | $ | 43,867 |
| | $ | 1,782,318 |
|
Net proceeds from sale of common shares | 214 |
| | 383,462 |
| | — |
| | — |
| | 383,676 |
| | — |
| | — |
| | — |
| | 383,676 |
|
Restricted share award grants, net | 2 |
| | 805 |
| | (346 | ) | | — |
| | 461 |
| | — |
| | — |
| | — |
| | 461 |
|
Purchase of OP Units | — |
| | — |
| | — |
| | — |
| | — |
| | (3,757 | ) | | — |
| | (3,757 | ) | | (3,757 | ) |
Conversion of OP Units | — |
| | 392 |
| | — |
| | — |
| | 392 |
| | (392 | ) | | — |
| | (392 | ) | | — |
|
Dividends/distributions declared | — |
| | — |
| | (70,901 | ) | | — |
| | (70,901 | ) | | (2,401 | ) | | — |
| | (2,401 | ) | | (73,302 | ) |
Preferred distributions | — |
| | — |
| | (399 | ) | | — |
| | (399 | ) | | — |
| | — |
| | — |
| | (399 | ) |
Issuance of OP Units in connection with acquisitions | — |
| | — |
| | — |
| | — |
| | — |
| | 44,259 |
| | — |
| | 44,259 |
| | 44,259 |
|
Contributions | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 47 |
| | 47 |
| | 47 |
|
Distributions | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | (210 | ) | | (210 | ) | | (210 | ) |
Buyout of Noncontrolling Interests - partially owned properties | — |
| | (2,800 | ) | | — |
| | — |
| | (2,800 | ) | | 719 |
| | (24 | ) | | 695 |
| | (2,105 | ) |
Change in fair value of interest rate cap agreements | — |
| | — |
| | — |
| | (780 | ) | | (780 | ) | | — |
| | — |
| | — |
| | (780 | ) |
Net income | — |
| | — |
| | 16,260 |
| | — |
| | 16,260 |
| | 461 |
| | 100 |
| | 561 |
| | 16,821 |
|
Adjustment for Noncontrolling Interests ownership in Operating Partnership | — |
| | 10,940 |
| | — |
| | — |
| | 10,940 |
| | (10,940 | ) | | — |
| | (10,940 | ) | | — |
|
Balance at June 30, 2017 | $ | 1,576 |
|
| $ | 2,313,443 |
|
| $ | (252,647 | ) |
| $ | 12,928 |
| | $ | 2,075,300 |
|
| $ | 71,091 |
|
| $ | 638 |
|
| $ | 71,729 |
|
| $ | 2,147,029 |
|
The accompanying notes are an integral part of this consolidated financial statement.
Physicians Realty Trust
Consolidated Statements of Cash Flows
(In thousands) (Unaudited)
|
| | | | | | | |
| Six Months Ended June 30, |
| 2017 | | 2016 |
Cash Flows from Operating Activities: | |
| | |
|
Net income | $ | 17,047 |
| | $ | 12,608 |
|
Adjustments to reconcile net income to net cash provided by operating activities | | | |
|
Depreciation and amortization | 56,056 |
| | 35,809 |
|
Amortization of deferred financing costs | 1,128 |
| | 947 |
|
Amortization of lease inducements and above/below market lease intangibles | 2,550 |
| | 1,989 |
|
Straight-line rental revenue/expense | (6,605 | ) | | (7,204 | ) |
Amortization of discount on unsecured senior notes | 98 |
| | — |
|
Amortization of above market assumed debt | (147 | ) | | (118 | ) |
Gain on sale of investment properties | (5,308 | ) | | — |
|
Equity in income of unconsolidated entities | (57 | ) | | (58 | ) |
Distributions from unconsolidated entities | 83 |
| | 27 |
|
Change in fair value of derivatives | 169 |
| | (67 | ) |
Provision for bad debts | (840 | ) | | 104 |
|
Non-cash share compensation | 807 |
| | 2,599 |
|
Write-off of contingent consideration | (70 | ) | | — |
|
Change in operating assets and liabilities: | |
| | |
|
Tenant receivables | 2,958 |
| | (1,001 | ) |
Other assets | 3,293 |
| | (3,081 | ) |
Accounts payable | 648 |
| | 1,079 |
|
Accrued expenses and other liabilities | 14,567 |
| | 15,908 |
|
Net cash provided by operating activities | 86,377 |
|
| 59,541 |
|
Cash Flows from Investing Activities: | |
| | |
|
Proceeds on sales of investment properties | 18,150 |
| | — |
|
Acquisition of investment properties, net | (756,862 | ) | | (872,497 | ) |
Escrowed cash - acquisition / earnest deposits | (19,577 | ) | | — |
|
Capital expenditures on existing investment properties | (8,343 | ) | | (6,980 | ) |
Real estate loans receivable | (8,594 | ) | | (3,478 | ) |
Repayment of note receivable | 16,423 |
| | 4,118 |
|
Repayment of real estate loan receivable | 1,507 |
| | 4,500 |
|
Leasing commissions | (1,209 | ) | | (116 | ) |
Lease inducements | (2,063 | ) | | (4,870 | ) |
Net cash used in investing activities | (760,568 | ) |
| (879,323 | ) |
Cash Flows from Financing Activities: | |
| | |
|
Net proceeds from sale of common shares | 383,676 |
| | 764,205 |
|
Proceeds from credit facility borrowings | 488,000 |
| | 528,000 |
|
Payment on credit facility borrowings | (529,000 | ) | | (545,000 | ) |
Proceeds from issuance of mortgage debt | 61,000 |
| | 21,500 |
|
Proceeds from issuance of senior unsecured notes | 396,108 |
| | 150,000 |
|
Principal payments on mortgage debt | (36,440 | ) | | (1,089 | ) |
Debt issuance costs | (1,065 | ) | | (4,313 | ) |
Dividends paid - shareholders | (65,529 | ) | | (44,151 | ) |
Distributions to noncontrolling interest - Operating Partnership | (1,917 | ) | | (1,616 | ) |
Preferred distributions paid - OP Unit holder | (519 | ) | | (704 | ) |
Contributions from noncontrolling interest | 47 |
| | — |
|
Distributions to noncontrolling interest - partially owned properties | (434 | ) | | (363 | ) |
Purchase of Series A Preferred Units | (19,961 | ) | | (9,756 | ) |
Purchase of OP Units | (3,757 | ) | | (2,129 | ) |
Net cash provided by financing activities | 670,209 |
|
| 854,584 |
|
Net increase (decrease) in cash and cash equivalents | (3,982 | ) | | 34,802 |
|
Cash and cash equivalents, beginning of period | 15,491 |
| | 3,143 |
|
Cash and cash equivalents, end of period | $ | 11,509 |
|
| $ | 37,945 |
|
Supplemental disclosure of cash flow information - interest paid during the period | $ | 14,876 |
| | $ | 4,300 |
|
Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements | $ | (780 | ) | | $ | — |
|
Supplemental disclosure of noncash activity - assumed debt | $ | 26,379 |
| | $ | — |
|
Supplemental disclosure of noncash activity - issuance of OP Units in connection with acquisitions | $ | 44,978 |
| | $ | 6,869 |
|
Supplemental disclosure of noncash activity - contingent consideration | $ | — |
| | $ | 156 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Balance Sheets
(in thousands, except share and per share data) |
| | | | | | | |
| June 30, 2017 | | December 31, 2016 |
| (unaudited) | | |
ASSETS | |
| | |
|
Investment properties: | | | |
Land and improvements | $ | 207,034 |
| | $ | 189,759 |
|
Building and improvements | 3,117,371 |
| | 2,402,643 |
|
Tenant improvements | 18,561 |
| | 14,133 |
|
Acquired lease intangibles | 381,875 |
| | 301,462 |
|
| 3,724,841 |
| | 2,907,997 |
|
Accumulated depreciation | (229,633 | ) | | (181,785 | ) |
Net real estate property | 3,495,208 |
| | 2,726,212 |
|
Real estate loans receivable | 47,923 |
| | 39,154 |
|
Investment in unconsolidated entity | 2,232 |
| | 2,258 |
|
Net real estate investments | 3,545,363 |
| | 2,767,624 |
|
Cash and cash equivalents | 11,509 |
| | 15,491 |
|
Tenant receivables, net | 5,991 |
| | 9,790 |
|
Other assets | 103,028 |
| | 95,187 |
|
Total assets | $ | 3,665,891 |
| | $ | 2,888,092 |
|
LIABILITIES AND CAPITAL | | | |
Liabilities: | | | |
Credit facility | $ | 603,585 |
| | $ | 643,742 |
|
Notes payable | 619,675 |
| | 224,330 |
|
Mortgage debt | 173,958 |
| | 123,083 |
|
Accounts payable | 5,071 |
| | 4,423 |
|
Dividends and distributions payable | 38,381 |
| | 32,179 |
|
Accrued expenses and other liabilities | 51,042 |
| | 42,287 |
|
Acquired lease intangibles, net | 15,183 |
| | 9,253 |
|
Total liabilities | 1,506,895 |
| | 1,079,297 |
|
| | | |
Redeemable noncontrolling interest - Series A Preferred Units (2016) and partially owned properties | 11,967 |
| | 26,477 |
|
| | | |
Capital: | | | |
Partners’ capital: | | | |
General partners’ capital, 157,677,566 and 135,966,013 units issued and outstanding as of June 30, 2017 and December 31, 2016, respectively | 2,062,372 |
| | 1,724,743 |
|
Limited partners’ capital, 5,399,265 and 3,436,207 units issued and outstanding as of June 30, 2017 and December 31, 2016, respectively | 71,091 |
| | 43,142 |
|
Accumulated other comprehensive income | 12,928 |
| | 13,708 |
|
Total partners’ capital | 2,146,391 |
| | 1,781,593 |
|
Noncontrolling interest - partially owned properties | 638 |
| | 725 |
|
Total capital | 2,147,029 |
| | 1,782,318 |
|
Total liabilities and capital | $ | 3,665,891 |
| | $ | 2,888,092 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Statements of Income
(in thousands, except unit and per unit data) (Unaudited)
|
| | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
| 2017 | | 2016 | | 2017 | | 2016 |
Revenues: | |
| | |
| | |
| | |
|
Rental revenues | $ | 58,015 |
| | $ | 42,196 |
| | $ | 117,107 |
| | $ | 77,051 |
|
Expense recoveries | 16,108 |
| | 9,552 |
| | 32,462 |
| | 17,455 |
|
Interest income on real estate loans and other | 2,476 |
| | 1,468 |
| | 3,696 |
| | 2,844 |
|
Total revenues | 76,599 |
| | 53,216 |
| | 153,265 |
| | 97,350 |
|
Expenses: | | | | | | | |
Interest expense | 11,472 |
| | 4,279 |
| | 21,287 |
| | 8,476 |
|
General and administrative | 6,249 |
| | 4,926 |
| | 10,985 |
| | 9,047 |
|
Operating expenses | 20,519 |
| | 13,798 |
| | 42,608 |
| | 24,835 |
|
Depreciation and amortization | 28,123 |
| | 19,799 |
| | 56,056 |
| | 35,809 |
|
Acquisition expenses | 5,242 |
| | 3,256 |
| | 10,647 |
| | 6,633 |
|
Total expenses | 71,605 |
| | 46,058 |
| | 141,583 |
| | 84,800 |
|
Income before equity in income of unconsolidated entities and gain on sale of investment properties: | 4,994 |
| | 7,158 |
| | 11,682 |
| | 12,550 |
|
Equity in income of unconsolidated entities | 29 |
| | 26 |
| | 57 |
| | 58 |
|
Gain on sale of investment properties | 5,308 |
| | — |
| | 5,308 |
| | — |
|
Net income | 10,331 |
| | 7,184 |
| | 17,047 |
| | 12,608 |
|
Net income attributable to noncontrolling interests - partially owned properties (1) | (159 | ) | | (60 | ) | | (326 | ) | | (377 | ) |
Net income attributable to controlling interest | 10,172 |
| | 7,124 |
| | 16,721 |
| | 12,231 |
|
Preferred distributions | (188 | ) | | (437 | ) | | (399 | ) | | (985 | ) |
Net income attributable to common unitholders | $ | 9,984 |
| | $ | 6,687 |
| | $ | 16,322 |
| | $ | 11,246 |
|
Net income per common unit: | | | | | | | |
Basic | $ | 0.06 |
| | $ | 0.05 |
| | $ | 0.11 |
| | $ | 0.09 |
|
Diluted | $ | 0.06 |
| | $ | 0.05 |
| | $ | 0.11 |
| | $ | 0.09 |
|
Weighted average common units: | | | | | | | |
Basic | 160,765,345 |
| | 135,351,672 |
| | 151,520,407 |
| | 120,951,069 |
|
Diluted | 161,012,360 |
| | 135,944,722 |
| | 151,912,432 |
| | 121,575,247 |
|
Distributions declared per common unit | $ | 0.230 |
| | $ | 0.225 |
| | $ | 0.455 |
| | $ | 0.450 |
|
| |
(1) | Includes amounts attributable to redeemable noncontrolling interests. No such adjustments are required for the three and six months ended June 30, 2016. |
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Statements of Comprehensive Income
(in thousands) (Unaudited)
|
| | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
| 2017 | | 2016 | | 2017 | | 2016 |
Net income | $ | 10,331 |
| | $ | 7,184 |
| | $ | 17,047 |
| | $ | 12,608 |
|
Other comprehensive income: | | | | | | | |
Change in fair value of interest rate swap agreements | (2,367 | ) | | — |
| | (780 | ) | | — |
|
Total other comprehensive income | (2,367 | ) | | — |
| | (780 | ) | | — |
|
Comprehensive income | 7,964 |
| | 7,184 |
| | 16,267 |
| | 12,608 |
|
Comprehensive income attributable to noncontrolling interests - partially owned properties | (159 | ) | | (60 | ) | | (326 | ) | | (377 | ) |
Comprehensive income attributable to common unitholders | $ | 7,805 |
| | $ | 7,124 |
| | $ | 15,941 |
| | $ | 12,231 |
|
The accompanying notes are an integral part of these consolidated financial statements.
Physicians Realty L.P.
Consolidated Statement of Changes in Capital
(in thousands) (Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | |
| General Partner | | Limited Partner | | Accumulated Other Comprehensive Income | | Total Partners’ Capital | | Partially Owned Properties Noncontrolling Interest | | Total Partners’ Capital |
Balance at January 1, 2017 | 1,724,743 |
| | 43,142 |
| | 13,708 |
| | 1,781,593 |
| | 725 |
| | 1,782,318 |
|
Net proceeds from sale of common shares | 383,676 |
| | — |
| | — |
| | 383,676 |
| | — |
| | 383,676 |
|
Restricted share award grants, net | 461 |
| | — |
| | — |
| | 461 |
| | — |
| | 461 |
|
Purchase of OP Units | — |
| | (3,757 | ) | | — |
| | (3,757 | ) | | — |
| | (3,757 | ) |
Conversion of OP Units | 392 |
| | (392 | ) | | — |
| | — |
| | — |
| | — |
|
OP Units - distributions | |